Pediatric Clinical Trials MarketSize and Trends

Global pediatric clinical trials market is estimated to be valued at US$ 14,869.5 million in 2022 and is expected to exhibit a CAGR of 9.3% during the forecast period (2022-2030).

Figure 1. Global Pediatric Clinical Trials Market Share (%), by Clinical Trial Phase, 2022

Increasing demand for new vaccines and other biologic products to prevent various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis is expected to drive the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC) factsheet in 2018, around 470,000 children had active epilepsy in the U.S., which was estimated to be around 0.6% of children aged 0-17 years.

Figure 2. Global Pediatric Clinical Trials Market Share (%), by Region, 2022

Increasing population of children is expected to drive market growth during the forecast period.

Increasing population of children is expected to drive market growth during the forecast period. For instance, according to Humanium, which is an international child sponsorship Non-Governmental Organisation (NGO) dedicated to stopping violations of children’s rights throughout the world, stated that the pediatric population in 2021 was about 2.2 billion globally.

Global Pediatric Clinical Trials Market– Impact of Coronavirus (COVID-19) Pandemic

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. Furthermore, according to the Centers for Disease Control and Prevention, as of April 2, 2020, around 2,572 (1.7%) cases of COVID-19 were registered in patients younger than 18 years in the U.S. Therefore, market players and research institutes are focusing on research and development activities by initiating clinical trials of drugs for the preventment of COVID-19 in children. Similarly, the University of Calgary, which is a public research university located in Alberta, Canada, initiated an observational study on March 18, 2020 to determine the clinical characteristics and outcomes of children potentially infected by COVID-19. Furthermore, research institutes are conducting observational studies to understand the impact of COVID-19 in various hospital departments. For instance, the South Egypt Cancer Institute, which provide medical education, training of researchers and physicians in the oncology field, initiated an observational study on May 15, 2020 to determine the effect of the COVID-19 pandemic on patients in the pediatric cancer care divisions in Egypt and the UAE.